Development and pharmacological characterization of novel multi‐ calcitonin gene‐related peptide and pituitary adenylate cyclase‐activating peptide receptor antagonists

Overview of attention for article published in Headache: The Journal of Head & Face Pain, February 2025

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (90th percentile)
High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

news: 1 news outlet
twitter: 11 X users

reddit: 1 Redditor
bluesky: 1 Bluesky user

Readers on

mendeley: 11 Mendeley

So far, Altmetric has seen 15 X posts from 11 X users, with an upper bound of 25,109 followers.

RT @Alex__Jaimes: 🧠 New research in @HeadacheJournal presents a breakthrough in migraine treatment: a single molecule that simultaneously b…

論文紹介：より強力な頭痛予防薬への期待近年、片頭痛の原因となる炎症物質を阻害する薬剤の開発が盛んです。炎症物質CGRPに対する薬剤が現在の片頭痛予防治療の王道になってきています。いわゆるエムガルティやアジョビ、アイモビーグですね。一方で、炎症物質PACAP…

論文紹介：より強力な頭痛予防薬への期待近年、片頭痛の原因となる炎症物質を阻害する薬剤の開発が盛んです。炎症物質CGRPに対する薬剤が現在の頭痛治療の王道になってきています。エムガルティやアジョビ、アイモビーグですね。一方で、炎症物質PACAPを阻害する新し…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 11 additional X posts.